⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL126328 | 0.96 | — | — | |
| Ethane SCHEMBL28046727 | 0.93 | — | — | |
| SCHEMBL28298061 | 0.93 | — | — | |
| Acetic Acid SCHEMBL11276111 | 0.84 | FFAR3 (0.41) | — | |
| Sulfuric Acid SCHEMBL27558365 | 0.81 | CA5A (0.46) | — | |
| SCHEMBL14796236 | 0.78 | — | — | |
| SCHEMBL31019742 | 0.78 | NPSR1 (0.34) | — | |
| SCHEMBL7608901 | 0.77 | — | — | |
| Sulfuric Acid SCHEMBL30340417 | 0.77 | — | — | |
| Sulfuric Acid SCHEMBL29046204 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104380469-B | Nano wire functionalization, dispersion and adherence method | 索尔伏打电流公司 | 2018-06-22 | — | — | CN | claimed |
| CN-107556422-A | Prepare P (VDF DB) g S C3H6‑SO3The method of H proton exchange membrane materials | 西安交通大学 | 2018-01-09 | — | — | CN | claimed |
| CN-105418687-A | [FeFe] hydrogenase model compound containing sodium disulfonate and preparation method for [FeFe] hydrogenase model compound | UNIV NANKAI | 2016-03-23 | — | — | CN | claimed |
| CN-105259167-A | Preparation method and application of molecularly-imprinted electrochemiluminescence sensing material | UNIV TIANJIN SCIENCE & TECH | 2016-01-20 | — | — | CN | claimed |
| CN-104380469-A | Methods of nanowire functionalization, dispersion, alignment and attachment | SOL VOLTAICS AB | 2015-02-25 | — | — | CN | claimed |
| CN-1354740-A | Pharmaceutical compounds | NICOX SA (FR) | 2002-06-19 | — | — | CN | claimed |
| WO-2023083361-A1 | NEW METHOD FOR IMPROVING QUALITY OF PLATELETS | 上海循曜生物科技有限公司 | 2023-05-19 | — | — | WO | disclosed |
| CN-109072203-B | Mirror image nucleic acid replication system | 清华大学 | 2023-04-04 | — | — | CN | disclosed |
| CN-115724847-A | 2, 3-dihydroimidazo [1,2-c ] quinazoline substituted derivatives | 拜耳知识产权有限责任公司 | 2023-03-03 | — | — | CN | disclosed |
| CN-114949237-A | Vesicle | 斯昆申技术控股有限责任公司 | 2022-08-30 | — | — | CN | disclosed |
| CN-108774232-B | 2, 3-dihydroimidazo [1,2-c ] quinazoline substituted derivatives | 拜耳知识产权有限责任公司 | 2022-08-09 | — | — | CN | disclosed |
| CN-107108527-B | Ataxia telangiectasia and Rad 3-Associated (ATR) protein kinase inhibitors | 阿特林制药有限责任公司 | 2022-08-02 | — | — | CN | disclosed |
| CN-108617166-B | Protein kinase inhibitor benzolactam compounds | 大冢制药株式会社 | 2022-05-17 | — | — | CN | disclosed |
| EP-1045704-A1 | METHODS FOR QUENCHING PATHOGEN INACTIVATORS IN BIOLOGICAL MATERIALS | Cerus Corporation (US) | 2000-10-25 | — | — | EP | disclosed |
| CN-1263570-A | Process for making high quality very low profile copper foil and copper foil made therefrom | CIRCUIT FOIL USA INC (US) | 2000-08-16 | — | — | CN | disclosed |
| US-6103789-A | INCREASE FLUIDITY OF AQUEOUS CEMENT SLURRY AND MAINTAIN ITS VISCOSITY FOR PROLONGED TIMES, AT LEAST TWO HOURS | ELF ATOMCHEM ITALIA S.R.L. (IT) | 2000-08-15 | — | — | US | disclosed |
| EP-0976769-A2 | Hydrosoluble acrylic copolymers | Elf Atochem Italia S.r.l. (IT) | 2000-02-02 | — | — | EP | disclosed |
| WO-1999034839-A1 | METHODS FOR QUENCHING PATHOGEN INACTIVATORS IN BIOLOGICAL MATERIALS | CERUS CORPORATION (US) | 1999-07-15 | — | — | WO | disclosed |
| EP-0528864-A1 | OXIDATION STABLE DETERGENT ENZYMES | NOVO NORDISK A/S (DK) | 1993-03-03 | — | — | EP | disclosed |
| WO-1991016423-A1 | OXIDATION STABLE DETERGENT ENZYMES | NOVO NORDISK A/S (DK) | 1991-10-31 | — | — | WO | disclosed |